Orange Book product · Brand (NDA)

IZBA

TRAVOPROST

Brand (NDA)NDA 204822DISCN NOVARTIS

May 15, 2014

Approved

Brand (NDA)

Application

Not listed

TE code

Listed patents

Approval
FDA approval date of this drug product.
May 15, 2014
12 yr 3 mo ago
Today
Patent 9144561 expires
Listed drug product patent expiration.
Mar 13, 2029
in 2 yr 9 mo
Patent 8754123 expires
Listed drug product patent expiration.
May 19, 2029
in 3 yr
Patent 8178582 expires
Listed drug product patent expiration.
Oct 10, 2029
in 3 yr 4 mo
Patent 8722735 expires
Listed drug product patent expiration.
Oct 10, 2029
in 3 yr 4 mo

Active ingredient

TRAVOPROST

Strength

0.003% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

TE code

Not listed

Application

NDA 204822

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

Active-ingredient family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
Patent	Expires	In	Type
9144561	Mar 13, 2029	in 2 yr 9 mo	Product
8754123	May 19, 2029	in 3 yr	Product
8178582	Oct 10, 2029	in 3 yr 4 mo	Product
8722735	Oct 10, 2029	in 3 yr 4 mo	Product